Ypsomed Holding AG

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-04 to 2024-03🗂️ Report periods on file: 2023-04 to 2024-03, 2022

In its 2023-04 to 2024-03 reporting, Ypsomed Holding AG disclosed greenhouse gas emissions of 87.4K t CO2e. By scope: Scope 1: 2.4K t CO2e; Scope 2: 0 t CO2e; Scope 3: 84.9K t CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
87.4K t CO2e
2023-04 to 2024-03
⚡
Renewable Energy
76%
of total energy
♻️
Waste
1.3K tons
2023-04 to 2024-03
⚙️
Energy Use
43.2K MWh
2023-04 to 2024-03

📊 Emissions by Scope (2023-04 to 2024-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).2.4K t CO2e
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.0 t CO2e
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).84.9K t CO2e

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023-04 to 2024-0387.4K t CO2e

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce absolute GHG emissions from Scopes 1 and 2 by 32% by 2027
  • Reduce Scope 3 emissions by 52% per million CHF of value added by 2030

📅 Medium-term

  • Reduce absolute GHG emissions from Scopes 1 and 2 by 90% by 2030
  • Reduce Scope 3 emissions by 97% per million CHF of value added by 2040

🔭 Long-term

  • Net-zero greenhouse gas emissions across the entire value chain by 2040

🌱 ESG Focus Areas

Climate change & energyResource use & circular economyEmployee-related issuesRespect for human rights; Combatting corruptionAccess to healthcare

⚠️ Challenges & Risks +

  • Supply chain disruptions (infusion sets); high competitive pressure in the pharmaceutical sector.
  • Reducing Scope 3 emissions (97% per million CHF of value added by 2040).
  • Maintaining high employee satisfaction during growth and reorganization.

📋 Report Information

Reporting Period: 2023-04 to 2024-03
Frameworks: GRI, UN SDGs
Assurance: Independent external certification body